Clinical Outcomes and Treatment Intensification across Depression Subtypes in Patients Receiving Stepwise Pharmacotherapy over 24 Months
Despite similar long-term outcomes across MDD subtypes, variations in treatment intensity were crucial for achieving these results. Our findings suggest that tailoring treatment plans according to depressive subtype severity and characteristics is essential for effective management. Future research should investigate the genetic and biomolecular bases of these subtypes to further optimize treatment strategies.
Authors
- Min Jhon (ORCID: https://orcid.org/0000-0002-0408-768X)
- Jae‐Min Kim (ORCID: https://orcid.org/0000-0001-7409-6306)
- Honey Kim (ORCID: https://orcid.org/0000-0002-6533-9588)
- Il‐Seon Shin (ORCID: https://orcid.org/0000-0001-5370-7649)
- Hee‐Ju Kang (ORCID: https://orcid.org/0000-0002-4784-4820)
- Sung‐Wan Kim (ORCID: https://orcid.org/0000-0002-6739-2163)
- Ju‐Yeon Lee (ORCID: https://orcid.org/0000-0003-0653-7223)
- Ju-Wan Kim
Institutions
- Chonnam National University (KR)
Publication Details
- Journal
- Clinical Psychopharmacology and Neuroscience
- Published
- 2025-03-17
- DOI
- https://doi.org/10.9758/cpn.25.1283
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- Chonnam National University
- National Research Foundation of Korea
- Chungnam National University Hospital
- Ministry of Science and ICT, South Korea